DYNAVAX TECHNOLOGIES CORP (DVAX) Stock News

USA - NASDAQ:DVAX - US2681582019 - Common Stock

9.41 USD

-0.33 (-3.39%)

Last: 9/12/2025, 8:00:01 PM

9.42 USD

+0.01 (+0.11%)

After Hours: 9/12/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

DVAX Latest News, Press Relases and Analysis

All

Press Releases

17 days ago - By: Dynavax Technologies

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

23 days ago - By: Stocktwits - Mentions: PKW IWMW

News Image

Dynavax’s Experimental Shingles Vaccine Shows Positive Results In Study: Retail Expects Stock Rally To Continue Into Friday

23 days ago - By: Benzinga - Mentions: GSK

Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Study

23 days ago - By: Dynavax Technologies

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

a month ago - By: The Motley Fool

Dynavax (DVAX) Q2 Revenue Jumps 29%

a month ago - By: Zacks Investment Research - Mentions: IMTX

Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates

a month ago - By: Dynavax Technologies

Dynavax Reports Second Quarter 2025 Financial Results

a month ago - By: Benzinga - Mentions: GSAT PGY ADV REAL ...

Earnings Scheduled For August 7, 2025

3 months ago - By: Dynavax Technologies

Dynavax Comments on Glass Lewis Recommendation

a month ago - By: Zacks Investment Research - Mentions: PTGX

Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates

2 months ago - By: Dynavax Technologies

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

2 months ago - By: Yahoo Finance - Mentions: BCRX

Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31

3 months ago - By: Dynavax Technologies

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

3 months ago - By: Deep Track Capital, LP

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

3 months ago - By: Dynavax Technologies

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

3 months ago - By: Deep Track Capital, LP

Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies

4 months ago - By: Dynavax Technologies

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

4 months ago - By: Deep Track Capital, LP

Deep Track Capital Comments on ISS Recommendation

5 months ago - By: Dynavax Technologies

Dynavax Files Preliminary Proxy Statement

4 months ago - By: Dynavax Technologies

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

4 months ago - By: Deep Track Capital, LP

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

4 months ago - By: Dynavax Technologies

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

4 months ago - By: Zacks Investment Research

Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why

4 months ago - By: Dynavax Technologies

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

4 months ago - By: Zacks Investment Research - Mentions: DTIL

Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates

4 months ago - By: Dynavax Technologies

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

4 months ago - By: Deep Track Capital, LP

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

5 months ago - By: Dynavax Technologies

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

5 months ago - By: Dynavax Technologies

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

5 months ago - By: Deep Track Capital, LP

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

5 months ago - By: Zacks Investment Research - Mentions: GSK ADMA

GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP

5 months ago - By: Dynavax Technologies

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

5 months ago - By: Deep Track Capital, LP

Deep Track Capital Comments on Dynavax Technologies’ Rejection of Most Recent Settlement Offer

6 months ago - By: Yahoo Finance - Mentions: COIN CORZ CORT IRWD ...

Coinbase Shares Head for Worst Quarter Since FTX Collapse as Crypto Slumps